Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trigger point injection with lidocaine for myofascial pain in advanced cancer
jRCTs051210132Completed
- Sponsor
- Japanese Society for Palliative Medicine
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine in chronic myofascial pain (CMP) (2 arms), sponsored by Japanese Society for Palliative Medicine. Started Jan 2022; status: completed.
02
Drugs
lidocaine
03
Conditions
chronic myofascial pain (CMP)
Beyond the preview
Go deeper on jRCTs051210132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051210132.